List view / Grid view

News

FDA grants QIDP for C. Difficile IV treatment

25 July 2016 | By Niamh Louise Marriott, Digital Content Producer

Morphochem announced today that the U.S. FDA has designated Morphochem’s intravenous antibacterial product as a Qualified Infectious Disease Product...

UCB and Amgen submit FDA application for Osteoporosis drug

22 July 2016 | By Niamh Louise Marriott, Digital Content Producer

UCB and Amgen today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for romosozumab, an investigational, monoclonal antibody for the treatment of osteoporosis in postmenopausal women at increased risk of fracture...

Combining soft-tissue cancer drugs improves survival

21 July 2016 | By Niamh Louise Marriott, Digital Content Producer

Scientists discovered that adding a novel monoclonal antibody therapy to traditional chemotherapy increased survival by nearly a year in patients with advanced sarcoma, a lethal soft-tissue cancer.

$3 million grant given for ALS trials

21 July 2016 | By Niamh Louise Marriott, Digitial Content Producer

Almost $3 million in funding to support a Phase II trial of a new therapeutic approach, developed by Amylyx, for the treatment of ALS...

Cancer treatment receives EU drug designations

20 July 2016 | By Niamh Louise Marriott, Digital Content Producer

With the EU orhpan drug designations, Cell Medica can now obtain regulatory and financial incentives for developing and marketing CMD-003 as a cancer...